8 January 2026
Sidley Represents BioRender in Investment Valuing Company at $900 Million
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Michael Podolny Lead | Sidley | Not stated | Emerging Companies and Venture Capital | Not stated |
| Chloe Kaufman | Sidley | Not stated | Emerging Companies and Venture Capital | Not stated |
| Celine Gruaz | Sidley | Not stated | Emerging Companies and Venture Capital | Not stated |
| Nicholas Frey | Sidley | Not stated | Employee Benefits and Executive Compensation | Not stated |
| Jonathan Westreich | Sidley | Not stated | Tax | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 900m ($900 million)
- What the figure measures
- Enterprise value
- Client
- BioRenderIssuer
- Counterparties
- Dimension Capital (Investor)